115 related articles for article (PubMed ID: 9396618)
1. Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo.
Morris AD; Léonce S; Guilbaud N; Tucker GC; Pérez V; Jan M; Cordi AA; Pierré A; Atassi G
Anticancer Drugs; 1997 Sep; 8(8):746-55. PubMed ID: 9396618
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and angiostatic activity of suramin analogues.
Firsching A; Nickel P; Mora P; Allolio B
Cancer Res; 1995 Nov; 55(21):4957-61. PubMed ID: 7585536
[TBL] [Abstract][Full Text] [Related]
3. Angiostatic effects of suramin analogs in vitro.
Firsching-Hauck A; Nickel P; Yahya C; Wandt C; Kulik R; Simon N; Zink M; Nehls V; Allolio B
Anticancer Drugs; 2000 Feb; 11(2):69-77. PubMed ID: 10789588
[TBL] [Abstract][Full Text] [Related]
4. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
[TBL] [Abstract][Full Text] [Related]
5. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor.
Manetti F; Cappello V; Botta M; Corelli F; Mongelli N; Biasoli G; Borgia AL; Ciomei M
Bioorg Med Chem; 1998 Jul; 6(7):947-58. PubMed ID: 9730230
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic and antiproliferative activity of suramin analogues.
Gagliardi AR; Kassack M; Kreimeyer A; Muller G; Nickel P; Collins DC
Cancer Chemother Pharmacol; 1998; 41(2):117-24. PubMed ID: 9443624
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.
Powis G; Seewald MJ; Melder D; Hoke M; Gratas C; Christensen TA; Chapman DE
Cancer Chemother Pharmacol; 1992; 31(3):223-8. PubMed ID: 1464160
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phospholipase D by agents that inhibit cell growth.
Gratas C; Powis G
Anticancer Res; 1993; 13(4):1239-44. PubMed ID: 8352550
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues.
Marchetti D; Reiland J; Erwin B; Roy M
Int J Cancer; 2003 Mar; 104(2):167-74. PubMed ID: 12569571
[TBL] [Abstract][Full Text] [Related]
11. Eriochrome Black T inhibits endothelial cell growth through S-phase blockade.
Langer I; Atassi G; Robberecht P; Résibois A
Eur J Pharmacol; 2000 Jul; 399(2-3):85-90. PubMed ID: 10884506
[TBL] [Abstract][Full Text] [Related]
12. Suramin analogs inhibit human angiogenesis in vitro.
Meyers MO; Gagliardi AR; Flattmann GJ; Su JL; Wang YZ; Woltering EA
J Surg Res; 2000 Jun; 91(2):130-4. PubMed ID: 10839961
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis by suramin.
Gagliardi A; Hadd H; Collins DC
Cancer Res; 1992 Sep; 52(18):5073-5. PubMed ID: 1381276
[TBL] [Abstract][Full Text] [Related]
14. Suramin inhibits C6 glioma-induced angiogenesis in vitro.
Coomber BL
J Cell Biochem; 1995 Jun; 58(2):199-207. PubMed ID: 7545684
[TBL] [Abstract][Full Text] [Related]
15. Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.
Bojanowski K; Lelievre S; Markovits J; Couprie J; Jacquemin-Sablon A; Larsen AK
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3025-9. PubMed ID: 1313577
[TBL] [Abstract][Full Text] [Related]
16. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth.
Fotsis T; Zhang Y; Pepper MS; Adlercreutz H; Montesano R; Nawroth PP; Schweigerer L
Nature; 1994 Mar; 368(6468):237-9. PubMed ID: 7511798
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N
Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120
[TBL] [Abstract][Full Text] [Related]
18. The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
Lopez Lopez R; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
Eur J Cancer; 1994; 30A(10):1545-9. PubMed ID: 7833116
[TBL] [Abstract][Full Text] [Related]
19. Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients.
Dhar S; Gullbo J; Csoka K; Eriksson E; Nilsson K; Nickel P; Larsson R; Nygren P
Eur J Cancer; 2000 Apr; 36(6):803-9. PubMed ID: 10762755
[TBL] [Abstract][Full Text] [Related]
20. Suramin inhibits glioma cell proliferation in vitro and in the brain.
Takano S; Gately S; Engelhard H; Tsanaclis AM; Brem S
J Neurooncol; 1994; 21(3):189-201. PubMed ID: 7699415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
